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BACKGROUND: Rectal bleeding is a recognised early symptom of colorectal cancer. This study aimed to assess the diagnostic accuracy
of symptoms, signs and diagnostic tests in patients with rectal bleeding in relation to risk of colorectal cancer in primary care.
METHODS: Diagnostic accuracy systematic review. Medline (1966 to May 2009), Embase (1988 to May 2009), British Nursing Index
(1991 to May 2009) and PsychINFO (1970 to May 2009) were searched. We included cohort studies that assessed the diagnostic
utility of rectal bleeding in combination with other symptoms, signs and diagnostic tests in primary care. An eight-point quality
assessment tool was produced to assess the quality of included studies. Pooled positive likelihood ratios (PLRs), sensitivities and
specificities were calculated.
RESULTS: Eight studies incorporating 2323 patients were included. Average weighted prior probability of colorectal cancer was 7.0%
(range: 3.3–15.4%, median: 8.1%). AgeX60 years (pooled PLR: 2.79, 95% confidence interval (CI) 2.00–3.90), weight loss (pooled
PLR: 1.89, 95% CI: 1.03–3.07) and change in bowel habit (pooled PLR: 1.92, 95% CI: 0.54–3.57) raise the probability of colorectal
cancer into the range of referral to secondary care but do not conclusively ‘rule in’ the diagnosis. Presence of severe anaemia has the
highest diagnostic value (pooled PLR: 3.67, 95% CI: 1.30–10.35), specificity 0.95 (95% CI: 0.93–0.96), but still only generates a post-
test probability of 21.6%.
CONCLUSIONS: In patients with rectal bleeding who present to their general practitioner, additional ‘red flag’ symptoms have modest
diagnostic value. These findings have implications in relation to recommendations contained in clinical practice guidelines.
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Published online 24 November 2009
& 2010 Cancer Research UK
Keywords: rectal bleeding; diagnosis; colorectal cancer; primary care



























































Patients presenting with symptoms of rectal bleeding commonly
seek medical advice in primary care (Chaplin et al, 2000). A Dutch
national survey on primary care revealed an incidence of rectal
bleeding of 1.6 per 1000 (95% confidence interval (CI): 1.4–1.8)
people in the general population seeking medical help from their
general practitioner (Linden et al, 2004). However, the majority of
patients with rectal bleeding in primary care do not have serious
disease, with estimates of the risk of colorectal cancer varying
between 2.4 and 11.0% (Douek et al, 1999; du Toit et al, 2006).
As rectal bleeding is a recognised early symptom of colorectal
cancer, primary care has an important role in its early detection
(Jones and Kennedy, 1999). Timely and efficient referral leading to
early diagnosis of colorectal cancer may contribute to improved
survival (Gondos et al, 2008). Current UK guidelines recommend
urgent referral of patients aged 40 years and older who report
rectal bleeding with a change of bowel habit towards looser stools
and/or increased stool frequency persisting for 6 weeks or more.
Patients aged above 60 years should be urgently referred if they
have rectal bleeding alone or changed bowel habit without anal
symptoms for 6 weeks or more (National Institute for Health
and Clinical Excellence, 2005). Referring patients at low risk of
colorectal cancer may lead to unnecessary harm (patient anxiety
and iatrogenic harm from further diagnostic investigations) and
longer waiting time for high-risk patients. An observational
study in the United Kingdom reported an average time interval
of 47 days between symptom presentation and diagnosis
(Barrett et al, 2006).
The incidence of colorectal cancer in people experiencing rectal
bleeding in the general population is o1 per 1000 people, and
increases to 20–110 per 1000 patients in a primary care setting,
and to 360 per 1000 patients in a secondary care setting
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(Fijten et al, 1994). These differing incidences reflect the increasing
probability of colorectal cancer in each community and hospital
setting. In general, two selection processes occur as a patient seeks
medical help and is assessed in primary care. First, a patient with
rectal bleeding decides whether or not to visit a general practitioner
regarding his/her symptom of rectal bleeding. About 28–41% of
people experiencing rectal bleeding consult their general practi-
tioner (Crosland and Jones, 1995; Thompson et al, 2000). Second,
their general practitioner performs a gate-keeping function,
prioritising patients in terms of probability of colorectal cancer.
The aim of this diagnostic accuracy systematic review is to
assess the additional diagnostic value of concurrent symptoms,
signs and diagnostic tests in patients presenting to their general
practitioner with rectal bleeding to stratify patients into low,
medium or high probability groups of colorectal cancer and assist
clinical decision making in primary care.
MATERIALS AND METHODS
Search strategy
An electronic search was performed using Medline (1966 to May
2009), Embase (1988 to May 2009), British Nursing Index (1991 to
May 2009) and PsychINFO (1970 to May 2009). Combinations of
MeSH terms and text words were used including: ‘Anal/ Rectal/
Colorectal/ Gastrointestinal’, ‘Bleeding/ Haemorrhage’, ‘Colorectal
cancer/ Neoplasm’, ‘General Practice’, ‘Family Practice’ and
‘Primary Care’. Bibliographies and references of included studies,
review articles and clinical guidelines were also searched. An
unrestricted electronic search filter was used (Leeflang et al, 2008).
No restrictions were placed on language.
Study selection
Studies were independently selected by MOB and GF. If no
consensus was achieved, studies were assessed by a third
independent reviewer (TF). The inclusion and exclusion criteria
were as follows:
 Population: unselected symptomatic patients recruited from
a primary care setting presenting with the symptom of rectal
bleeding.
 Study design: prospective cohort studies in a general practice
setting. Other forms of observational studies, such as case–
control studies were excluded. Screening studies and all types
of retrospective studies were also excluded.
 Index test and reference standard: studies that investigate the
diagnostic accuracy of symptoms, signs and diagnostic tests in
relation colorectal cancer. Reference standard includes colono-
scopy, flexible sigmoidoscopy, rigid sigmoidoscopy, barium
enaema as well as follow-up over time.
 Outcome measures: Presence of colorectal cancer with data
enabling the construction of 2 2 tables for the assessment
of diagnostic accuracy of individual symptoms, signs or diag-
nostic tests.
Quality assessment
An eight-point quality assessment tool was created to assess
the quality of included studies. The assessment tool was applied
by two independent reviewers (MOB, GF) and includes criteria
from the studies by Whiting et al (2006) (QUADAS) and Laupacis
et al (1997).
Data extraction
Data from individual studies were independently extracted in
duplicate by two reviewers (MOB, GF). If studies were eligible for
inclusion, but data were insufficient to construct 2 2 tables,
authors were contacted and asked to provide additional informa-
tion.
Statistical analysis
A weighted average prior probability was calculated by adding up
the priors of the sub-studies, but multiplying the individual priors
by the proportion of patients in the sub-study in relation to the
total number of patients in all studies together, therefore, allowing
larger studies to have more influence on the prior. It is calculated
in a following way: ((prior study Xi (nstudyXi/ntotal)þyþ prior
study Xiþ x (nstudyXiþ x/ntotal))/number of included studies.
For the meta-analyses, a bivariate, random effects approach was
used (Reitsma et al, 2005). The bivariate, random effects model
focuses on estimating an average sensitivity and specificity, also
estimating the unexplained variation in these parameters and the
correlation between them. A summary estimate with a correspond-
ing confidence bound of the average sensitivity and specificity
across studies was computed for each symptom and sign. The
bivariate, random-effects model along with the hierarchical
summary receiver operating characteristic method are recom-
mended over the more traditional methods of meta-analysis
(Harbord et al, 2008). The DiagMeta package in R was used for the
meta-analyses in which data from at least four studies were
available (R Development Core Team, 2008), otherwise summary
receiver operating characteristic curves were constructed using the
random effects DerSimonian–Laird model (DerSimonian and
Laird, 1986).
In terms of estimating the clinical value of symptoms, signs and
test results, pooled likelihood ratios are estimated. Likelihood
ratios are the most accessible way to refine clinical diagnosis on
the basis of symptoms, signs and test results (Grimes and Schulz,
2005). A likelihood ratio41 indicates an increase in probability of
colorectal cancer, whereas a likelihood ratioo1 is associated with
a decrease in the probability colorectal cancer.
RESULTS
The search strategy identified 1534 potential relevant citations.
Eight studies met our inclusion criteria and were included in the
final analysis (Figure 1; Mant et al, 1989; Fijten et al, 1995; Metcalf
et al, 1996; Norrelund and Norrelund, 1996; Wauters et al, 2000;
Ellis and Thompson, 2005; Heintze et al, 2005; du Toit et al, 2006).
Characteristics of the included studies
The eight studies included 2323 patients and were carried out in
primary care settings in England (Metcalf et al, 1996; Ellis and
Thompson, 2005; du Toit et al, 2006), the Netherlands (Fijten et al,
1995), Germany (Heintze et al, 2005), Denmark (Norrelund and
Norrelund, 1996), Belgium (Wauters et al, 2000) and Australia
(Mant et al, 1989). The mean weighted prior probability of
colorectal cancer was 7.0% (range: 3.3–15.4%, median: 8.1%). All
studies included patients presenting with rectal bleeding in
primary care and assessed the diagnostic accuracy of additional
symptoms, signs and diagnostic tests. Summary characteristics of
each included study are presented in Table 1.
Quality of the included studies
The quality assessment of individual studies is presented in
Table 2. In six studies, either the entire population or a random
selection of the eligible population were subjected to a reference
standard. The remaining two studies did not apply a reference
standard to any of the included participants (Heintze et al, 2005;
du Toit et al, 2006). Only one study applied the same reference
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standard (colonoscopy) to all included participants (Metcalf
et al, 1996). Blinding of outcome assessment was poorly reported
(Table 2). A summary diagram of the quality assessment is shown
in Figure 2.
Definition of the reference standard test and follow up
A variety of reference standards were used: colonoscopy, rigid
sigmoidoscopy with (double contrast) barium enaema, air-contrast
barium enaema, flexible sigmoidoscopy, flexible sigmoidoscopy
and questionnaire, a questionnaire only, barium enaema only, and
proctoscopy with sonography. Only two studies describe how
many patients underwent a particular reference standard investi-
gation (Mant et al, 1989; Metcalf et al, 1996). Follow-up was
adequately described in three of the eight studies and ranged from,
at least, 12 to 32 months (Fijten et al, 1995; Norrelund and
Norrelund, 1996; Wauters et al, 2000). Follow-up was carried out
by either sending recall letters to the general practitioner to obtain
the number of all the new cases of cancer (Wauters et al, 2000),
microscopic verification of colorectal cancer or an yearly letter to
the general practitioner (Norrelund and Norrelund, 1996), or by
checking medical records and information provided by the general
practitioner (Fijten et al, 1995).
Diagnostic value of rectal bleeding and related symptoms,
signs and diagnostic tests
In the primary studies, all patients had rectal bleeding and
presented with additional symptoms. The pooled positive like-
lihood ratios (PLRs), sensitivities and specificities for individual
symptoms, signs and diagnostic tests are presented in Table 3.
Overall, the magnitudes of the pooled PLRs are modest, with no
individual symptom, sign or diagnostic test able to alter the
probability of colorectal cancer into a definite range of ‘ruling in’
or ‘ruling out’ the diagnosis of colorectal cancer. Even classical
symptoms, such as a history of weight loss and anaemia yield a
modest pooled positive likelihood ratio of 1.89 (95% CI: 1.03–3.07)
and 3.67 (95% CI: 1.30–10.35), respectively. Pooled sensitivities
are low, varying from 0.17 to 0.62. Weight loss and anaemia yield a
pooled specificity of 0.91 (95% CI: 0.83–0.96) and 0.95 (95% CI:
0.93–0.96), respectively (Table 3).
DISCUSSION
Principal results
No individual symptom, sign or diagnostic test in patients with
rectal bleeding is likely to shift the probability of colorectal cancer
to the extent of ‘ruling in’ or ‘ruling out’ the diagnosis with any
degree of certainty. Even the presence of anaemia (o12.0 g per
100ml for women and o13.3 g per 100ml for men) produces a
shift in post-test probability to 21.6% (assuming a prior
probability of 7.0%), a level that requires further diagnostic
testing before colorectal cancer diagnosis is confirmed. ‘Red flag’
symptoms, such as weight loss and blood mixed with stool, seem to
have only modest diagnostic value. Although the presence of these
symptoms nearly doubles the post-test probability of colorectal
cancer to about 13%, and their presence should ensure referral for
further investigation, caution is needed when counselling patients
about the possible reasons for their referral in terms of likely
diagnoses. The fact that a presenting patient may be aged over 60
Potentially relevant citations
(n = 1534)
Excluded after scanning of citation or abstract
(n = 1470)
Full text retrieved
(n = 64)
Excluded         (n = 56)
Reasons for exclusion: 
Setting not in general practice    (n = 23)
Screening study    (n = 5)
Case–control study              (n = 5)
Retrospective study               (n = 4)
Literature review               (n = 2)
Editorial                (n = 1)
Outcome of colorectal cancer not recorded   (n = 1)
Data not extractable from 2×2 tables           (n = 15)
Included studies
(n = 8)
Figure 1 Flow of studies through review process.
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years also only provides modest diagnostic value in terms of
probability of colorectal cancer (Table 3).
The findings from this systematic review have implications for
clinical practice guidelines, showing that considerable diagnostic
uncertainty is likely to exist in patients presenting to their general
practitioner, even when they have additional symptoms, signs or
test results that are conventionally associated with an increased
risk of colorectal cancer (Hamilton and Sharp, 2004). The ideal
threshold for referral is subject to several factors: individual
patient’s utilities or values regarding timely identification of
colorectal cancer balanced against the iatrogenic harm and
psychological damage of unnecessary investigation, and potential
harm in patients free from disease. In addition, cost effectiveness
of different referral thresholds in relation to probability of
colorectal cancer also needs to be considered. To resolve these
difficulties, formal cost utility estimates are required, which
incorporate patient’s utilities and cost at different referral
thresholds.
Context of previous studies
Our results differ from a recent UK case–control study that
assessed the diagnostic value of clinical features of colorectal
cancer before diagnosis. This study identified cases from a cancer
registry and controls selected and matched in terms of age and
registration with a general practice (Hamilton et al, 2005). In this
case–control study, PLRs were considerably higher than found in
this systematic review of cohort studies. For example, PLRs for
weight loss (5.1), abdominal pain (4.5) and anaemia o10 g per
100ml (9.5) would all be associated with definitive shifts in the
probability of colorectal cancer (Grimes and Schulz, 2005). The
most likely explanation for this discordant finding is that recall
bias amongst controls may have produced a comparison group
that did not remember having colorectal symptoms in the past,
thus inflating estimates of diagnostic utility for symptoms, signs
and diagnostic tests when compared with individuals with
colorectal cancer (Grimes and Schulz, 2002).
Our results are more consistent with a recent diagnostic
accuracy review of cohort studies that included patients in both
primary and secondary care presenting with ‘alarm’ features (Ford
et al, 2008). In their systematic review the overall conclusion was
that most alarm features of colorectal cancer had poor sensitivity
and specificity for the diagnosis of colorectal cancer. The presence
of rectal bleeding (PLR: 1.32, 95% CI: 1.19–1.47), weight loss (PLR:
1.96, 95% CI: 1.25–3.08) or iron deficiency anaemia (PLR: 1.43,
95% CI: 0.75–2.74) do raise the probability of colorectal cancer but
only to a modest extent. The results from this systematic review of
cohort studies in primary care, in which rectal bleeding was an
inclusion criterion, are broadly similar in relation to diagnostic
utility of symptoms, signs and diagnostic tests.
Our findings suggest that older age and iron deficiency anaemia
are predictive of colorectal cancer. These findings are consistent
with several previous studies. Panzuto et al (2003) showed that
age 450 years and iron deficiency anaemia are independently
associated with colorectal cancer in primary care (odds ratios: 9.0
and 8.8 on multivariable analysis, respectively). Patients with
right-sided bowel cancers have a significantly lower haemoglobin
level at presentation than those with left-sided cancers (Yates et al,
2004; Masson et al, 2007). There seems to be a trade-off in relation
to the diagnostic and prognostic value of the presence of anaemia
and colorectal cancer, whereas presence of anaemia is most useful
in ruling in a diagnosis of colorectal cancer, it is also associated
with a more advanced disease and a poorer prognosis (Stapley
et al, 2006).
Lastly, having a positive family history for colorectal cancer
has been cited as being associated with an increased risk of
current colorectal cancer (Bonelli et al, 1988; Slattery et al, 2003).
The three included studies assessing family history of colorectalT
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cancer yield varying and inconsistent likelihood ratios (Mant et al,
1989; Fijten et al, 1995; Heintze et al, 2005). Heintze et al (2005)
calculated a PLR of 3.65, whereas Fijten et al (1995) and Mant et al,
1989) reported a PLR o1. More research is needed regarding the
definition of positive family history, how it might relate to risk of
colorectal cancer and the impact of using family history as a
preliminary screening question prior to Faecal Occult Blood (FOB)
screening programs (Polmear and Glasziou, 2008).
Limitations of the present study
The validity of the results of this systematic review is determined
by an independent, unbiased selection process. However, any
systematic review may be susceptible to publication bias (Irwig
et al, 1994, 1995; Deeks, 2001). The quality of the review is
dependent on the quality of the included cohort studies. Several
dimensions that relate to the quality of the included studies are
unclear or inadequately reported (Table 2, online). This finding is
not intended as a criticism of the original studies, but is more a
reflection on the considerable challenges of undertaking cohort
studies in primary care settings that rely on complete identification
and follow-up of all eligible incident cases of rectal bleeding. For
instance, in one included study, general practitioners were asked
to include a maximum of three to four patients (Norrelund and
Norrelund, 1996). This prior selection may lead to a preferential
selection of more severe cases and subsequent spectrum bias,
Were selection criteria clearly described?
Was the spectrum of patients representative of the patients
who will receive the test in practice?
Were all outcome events and predictors clearly defined?
Did the whole sample or a random selection of the sample
receive verification using a reference standard?
Did patients receive the same reference standard regardless
of their symptoms and signs?
Is the reference standard likely to correctly classify the
target condition?
Were the reference standard results interpreted without
knowledge of the symptoms and signs?
Was there a 100% follow-up of those enrolled?
Were withdrawals from the study explained?
Yes No Unclear
0% 20% 40% 60% 80% 100%
Figure 2 Summary diagram of the quality assessment of included studies.
Table 3 Clinical value of symptoms and signs in patients presenting with rectal bleeding in terms of colorectal cancer
No of
studiesa
No of
patients Sens (95% CI) Spec (95% CI)
Pooled
PLR (95% CI)
Patient characteristics
Male 5 1253 0.58 (0.48–0.67) 0.52 (0.48–0.56) 1.21 (1.00–1.46)
Age o40 yearsb 2 745 0.03 (0.00–0.16) 0.73 (0.69–0.76) 0.32 (0.05–2.21)
Age 40–59 yearsb 4 1387 0.09 (0.04–0.19) 0.79 (0.70–0.86) 0.41 (0.18–0.90)
Age X 60 yearsb 6 1760 0.66 (0.45–0.83) 0.76 (0.68–0.83) 2.79 (2.00–3.90)
Family history colorectal cancer 3 886 0.15 (0.06–0.28) 0.85 (0.82–0.87) 1.05 (0.16–6.88)
Symptoms
Dark red bloodc 4 949 0.22 (0.13–0.34) 0.84 (0.69–0.93) 1.37 (0.59–3.30)
Weight loss 7 1737 0.17 (0.06–0.37) 0.91 (0.83–0.96) 1.89 (1.03–3.07)
Abdominal pain 7 1739 0.25 (0.04–0.62) 0.73 (0.52–0.89) 0.94 (0.19–1.59)
Changed bowel habit 5 1254 0.62 (0.18–0.94) 0.68 (0.53–0.80) 1.92 (0.54–3.57)
Blood mixed with the stool 5 1225 0.40 (0.04–0.93) 0.81 (0.23–0.98) 1.91 (0.75–5.51)
Previous history of rectal bleedingd 2 425 0.30 (0.05–0.41) 0.66 (0.63–0.71) 0.58 (0.14–1.41)
Perianal symptoms – pain on defecation 2 411 0.22 (0.13–0.36) 0.41 (0.22–0.78) 0.49 (0.25–0.97)
Perianal symptoms – itch/eczema 2 414 0.17 (0.07–0.33) 0.87 (0.73–0.95) 1.31 (0.25–6.21)
Signs and diagnostic tests
Rectal palpation – haemorrhoid 2 354 0.24 (0.09–0.45) 0.73 (0.46–0.91) 0.51 (0.09–2.97)
Anaemia (Hb ~o12.0 g per 100ml
#o13.3 g per 100ml)
2 700 0.17 (0.05–0.35) 0.95 (0.93–0.96) 3.67 (1.30–10.35)
Abbreviations: CI¼ confidence interval; Hb, haemoglobin; PLR¼ positive likelihood ratio. aNorrelund and Norrelund (1996) consists of two independent sub-studies, and
therefore are independently assessed. In the column ‘no of studies’ these two substudies are counted as two separate studies. bThere is a slight age overlap between the
individual studies. cThe reference category of dark red blood consists of patients having bright red blood or a colour in between. dThe reference category of previous history of
rectal bleeding consists of patients having a first episode of rectal bleeding.
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producing spurious clinical associations and overestimation of
likelihood ratios (Jelinek, 2008).
The other feature of included studies was the application of a
variety of different reference standards. In the detection of
colorectal cancer, the most sensitive and specific diagnostic test
is colonoscopy, followed by a flexible sigmoidoscopy in combina-
tion with a barium enaema (Irvine et al, 1988; Rex et al, 1990;
Helfand et al, 1997). In the included studies, a variety of reference
standard tests were used with a possibility of work-up bias in some
studies as lower-risk patents were subject to less rigorous reference
standard tests (Table 2). Other methodological problems include
incomplete or inadequate blinding of outcome assessment and
incomplete reporting on losses to follow-up (Table 2).
We found significant between-study heterogeneity for a range of
symptoms and signs (Table 3). This might be due to whether or
not rectal bleeding was the principal reason for consultation and
also the duration of rectal bleeding. Three included studies report
rectal bleeding as the primary complaint in 15%, 51% and 100%
of patients, respectively, (Fijten et al, 1995; Metcalf et al, 1996;
Wauters et al, 2000), and in terms of duration two studies excluded
patients with rectal bleeding longer than six and twelve months,
respectively (Mant et al, 1989; Metcalf et al, 1996).
For age categories, we calculated sensitivities, specificities and
likelihood ratios. However, primary studies use different age
cut-off points, which complicate the generation of reference
categories. In our review, there is a slight overlap in some of the
age categories, which may have affected the precision of pooled
estimates. In terms of dark red blood, the reference category
includes both patients with bright red blood and a colour in
between. For a history of rectal bleeding the reference category
consists of patients having a first episode of rectal bleeding.
Future studies
There are considerable challenges with undertaking cohort studies
of rectal bleeding in primary care, including recruitment of
consecutive patients; eliciting full history of symptoms, signs and
diagnostic tests; consenting ‘low risk’ patients to potentially
unpleasant and invasive reference standard tests, and ensuring
adequate follow-up of patients. Furthermore, the relative rarity of
colorectal cancer in primary care makes it difficult to design a
study large enough to yield adequate power to detected significant
clinical predictors of colorectal cancer (Hamilton and Sharp,
2004).
Despite these challenges, this systematic review shows that the
evidence base is not substantial at present and that further studies
are required, which assess the diagnostic accuracy of lower gastro-
intestinal symptoms in community settings. A study assessing the
combined value of rectal bleeding and additional symptoms has
been undertaken in secondary care, showing that patients presenting
with rectal bleeding and a change in bowel habit without perianal
symptoms are at highest risk of colorectal cancer (PLR: 4.2). Patients
with rectal bleeding and perianal symptoms, but without a change in
bowel habit had lowest risk of colorectal cancer (negative likelihood
ratio: 1.3) (Thompson et al, 2007). Similar studies, focussing on
patients presenting in primary care are needed.
Future studies should recruit consecutive patients, apply an
agreed reference standard to all patients and evaluate the
combined value of symptoms, signs and diagnostic tests in the
form of a clinical prediction rule (McGinn et al, 2008). Future
primary studies should also report their data completely,
preferably using the Standards for Reporting of Diagnostic
Accuracy (STARD) criteria as guidelines (Bossuyt et al, 2003).
In conclusion, this systematic review shows that no individual
symptom, sign or diagnostic test in patients with rectal bleeding is
likely to conclusively raise the probability of colorectal cancer in
primary care settings. Even conventionally stated ‘red flag’
symptoms, such as weight loss and blood mixed with stool, have
modest diagnostic value. Future studies are needed to establish the
diagnostic value of individual and combined symptoms, signs and
diagnostic tests so that the evidence base for appropriate and
timely referral is more secure.
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